Literature DB >> 19443906

Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress.

Marta Monge1, Eva Colas, Andreas Doll, Antonio Gil-Moreno, Josep Castellvi, Berta Diaz, Marta Gonzalez, Rafael Lopez-Lopez, Jordi Xercavins, Ramon Carreras, Francesc Alameda, Francesc Canals, Franco Gabrielli, Jaume Reventos, Miguel Abal.   

Abstract

Endometrial cancer, the most common gynecological malignancy in western countries, is characterized by a favorable prognosis. Nonetheless, deep myometrial invasion correlates with more undifferentiated tumors, lymph-vascular invasion, node involvement and decreased global survival. We have described previously the Ets family member ERM/ETV5 specifically upregulated in endometrial endometrioid carcinoma (EEC) associated with myometrial infiltration. To understand the role of this transcription factor during myometrial infiltration, we analyzed by two-dimension differential gel electrophoresis (2D-DIGE) technology those proteins whose expression was altered in endometrial cell lines stably overexpressing ERM/ETV5. Pathway analysis pointed to actin regulation and transforming growth factor beta and progesterone signaling as processes regulated by ERM/ETV5. In addition, we characterized the specific upregulation of the nuclear dehydrogenase/reductase Hep27 as well as its ERM/ETV5-dependent mitochondrial localization. Further functional studies demonstrated a protective role of Hep 27 against apoptosis induced by oxidative stress. Overall, the ETV5-related proteomic approach performed in the Hec-1A cell line reinforces a role of this transcription factor in the regulation of the migratory and invasive tumor behavior and points to a modulated response to oxidative stress associated with the promotion of invasion in endometrial cancer. Unraveling the molecular events in EEC associated with the initiation of tumor invasion would represent an obvious improvement in the pursuit of rational targets for the onset of metastasis. This knowledge would also be a valuable tool for the molecular stratification of patients since myometrial affectation determines an increase in the rate of recurrence after a first surgical treatment and a decrease in 5 year survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443906     DOI: 10.1093/carcin/bgp119

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  19 in total

1.  ERM/ETV5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progression.

Authors:  Vanessa Paiva Leite de Sousa; Claudia Bessa Pereira Chaves; Janina Ferreira Loureiro Huguenin; Fábio Carvalho de Barros Moreira; Bruno Souza Bianchi de Reis; Leila Chimelli; Anke Bergmann; Tatiana de Almeida Simão; Luis Felipe Ribeiro Pinto
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

2.  The role of Pea3 group transcription factors in esophageal squamous cell carcinoma.

Authors:  Hiu-Fung Yuen; Cian M McCrudden; Ka-Kui Chan; Yuen-Piu Chan; Michelle Lok-Yee Wong; Kelvin Yuen-Kwong Chan; Ui-Soon Khoo; Simon Law; Gopesh Srivastava; Terence R Lappin; Kwok-Wah Chan; Mohamed El-Tanani
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

3.  Glucose reintroduction triggers the activation of Nrf2 during experimental ischemia reperfusion.

Authors:  Daniel Crean; Luca Felice; Cormac T Taylor; Hamid Rabb; Paul Jennings; Martin O Leonard
Journal:  Mol Cell Biochem       Date:  2012-03-30       Impact factor: 3.396

4.  Selective effects of a fiber chimeric conditionally replicative adenovirus armed with hep27 gene on renal cancer cell.

Authors:  Lin Fang; Qian Cheng; Wenshun Liu; Jie Zhang; Yan Ge; Qi Zhang; Liantao Li; Junjie Liu; Junnian Zheng
Journal:  Cancer Biol Ther       Date:  2016-05-19       Impact factor: 4.742

Review 5.  The EMT signaling pathways in endometrial carcinoma.

Authors:  Eva Colas; Nuria Pedrola; Laura Devis; Tugçe Ertekin; Irene Campoy; Elena Martínez; Marta Llauradó; Marina Rigau; Mireia Olivan; Marta Garcia; Silvia Cabrera; Antonio Gil-Moreno; Jordi Xercavins; Josep Castellvi; Angel Garcia; Santiago Ramon y Cajal; Gema Moreno-Bueno; Xavier Dolcet; Francesc Alameda; Jose Palacios; Jaime Prat; Andreas Doll; Xavier Matias-Guiu; Miguel Abal; Jaume Reventos
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

6.  Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.

Authors:  Z G Gulzar; J K McKenney; J D Brooks
Journal:  Oncogene       Date:  2012-02-20       Impact factor: 9.867

7.  Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers.

Authors:  S Attarha; S Andersson; M Mints; S Souchelnytskyi
Journal:  Br J Cancer       Date:  2013-07-09       Impact factor: 7.640

8.  Quantifying differential gene connectivity between disease states for objective identification of disease-relevant genes.

Authors:  Jen-hwa Chu; Ross Lazarus; Vincent J Carey; Benjamin A Raby
Journal:  BMC Syst Biol       Date:  2011-05-31

9.  Impact of genomic stability on protein expression in endometrioid endometrial cancer.

Authors:  M I Lomnytska; S Becker; T Gemoll; C Lundgren; J Habermann; A Olsson; I Bodin; U Engström; U Hellman; K Hellman; A-C Hellström; S Andersson; M Mints; G Auer
Journal:  Br J Cancer       Date:  2012-03-13       Impact factor: 7.640

10.  Knock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cells.

Authors:  Stefanie Kewitz; Martin S Staege
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.